Cargando…
Therapeutic Strategies for Diabetes: Immune Modulation in Pancreatic β Cells
Increased incidence of type I and type II diabetes has been prevailed worldwide. Though the pathogenesis of molecular mechanisms remains still unclear, there are solid evidence that disturbed immune homeostasis leads to pancreatic β cell failure. Currently, autoimmunity and uncontrolled inflammatory...
Autores principales: | Jo, Sugyeong, Fang, Sungsoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415970/ https://www.ncbi.nlm.nih.gov/pubmed/34484126 http://dx.doi.org/10.3389/fendo.2021.716692 |
Ejemplares similares
-
Endogenous Pancreatic β Cell Regeneration: A Potential Strategy for the Recovery of β Cell Deficiency in Diabetes
por: Zhong, Fan, et al.
Publicado: (2019) -
Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic β Cells
por: Murakami, Takaaki, et al.
Publicado: (2022) -
Mechanisms and therapeutic strategies of immune checkpoint molecules and regulators in type 1 diabetes
por: Ding, Jia-Tong, et al.
Publicado: (2023) -
Pancreatic β-cell senescence in diabetes: mechanisms, markers and therapies
por: Cha, Jeeyeon, et al.
Publicado: (2023) -
Coexistence of Immune Checkpoint Inhibitor-Induced Autoimmune Diabetes and Pancreatitis
por: Zhang, Amy L., et al.
Publicado: (2021)